Clinical Trial Update: A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and efficacy of Eucrisa (Crisaborole) in seborrheic dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Seborrheic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2021-10-29